PharmTech
CONTINUE TO SITE

OR WAIT null SECS

Advertisement
Pharmaceutical Technology - Pharma News and Development Insights
Spotlight
AnalyticsDosage FormsDrug DevelopmentManufacturingOutsourcingQuality Systems
Topic
View MoreCOVID-19 UpdateAnalytical Method DevelopmentAPIsAseptic ProcessingBiologic DrugsDrug DeliveryEquipmentExcipientsFormulationPackagingProcess Control/PATProcess DevelopmentQA/QCRegulatory ActionSupply Chain
News
All NewsBio/Pharma News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions Podcast
Conferences
Conference CoverageConference Listing
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPartnersPeer-Reviewed ResearchPharma InsightsPharmTech ProductsSponsored eBooksSponsored PodcastsSponsored VideosState of the ScienceWhitepapers
Subscribe

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
  • MJHLS Brand Logo

© 2026 MJH Life Sciences and Pharmaceutical Technology - Pharma News and Development Insights. All rights reserved.

Buy, Sell, Hold: Cell and Gene Therapy

EP. 1: Buy, Sell, Hold: Cell and Gene Therapy - Part 1

October 11th 2024

Cell and gene therapy experts Fabian Gerlinghaus, Dr. Claudia Zylberberg, and Benjamin McLeod weigh in on hot topics in CGT.

EP. 2: Buy, Sell, Hold: Cell and Gene Therapy - Part 2

October 18th 2024

Cell and gene therapy experts Fabian Gerlinghaus, Dr. Claudia Zylberberg, and Benjamin McLeod weigh in on hot topics in CGT.

EP. 3: Buy, Sell, Hold: Cell and Gene Therapy - Part 3

October 18th 2024

Cell and gene therapy experts Fabian Gerlinghaus, Dr. Claudia Zylberberg, and Benjamin McLeod weigh in on hot topics in CGT.